These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23628974)

  • 1. Late autoimmune hepatitis after hepatitis C therapy.
    Efe C; Heurgué-Berlot A; Ozaslan E; Purnak T; Thiéfin G; Simsek H; Wahlin S
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1308-11. PubMed ID: 23628974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports.
    Casanovas T; Argudo A; Peña-Cala MC
    Transplant Proc; 2011; 43(6):2233-6. PubMed ID: 21839242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C.
    Efe C; Wahlin S; Ozaslan E; Purnak T; Muratori L; Quarneti C; Tatar G; Simsek H; Muratori P; Schiano TD
    Scand J Gastroenterol; 2013 Apr; 48(4):504-8. PubMed ID: 23448312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Difference between autoimmune hepatitis (AIH) with and without hepatitis C virus (HCV)].
    Hokari A; Zeniya M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):658-62. PubMed ID: 15359880
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
    Kerkar N; Yanni G
    J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of low accelerating dose regimen of interferon/ribavirin antiviral therapy in patients with hepatitis C virus recurrence after liver transplantation.
    Su H; Liu Z; Sun Y; Li H; Zhou S; Zhou X; Gao Y; Tang R; Zhang D; Zhang M
    Ann Transplant; 2015 May; 20():263-8. PubMed ID: 25975740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy.
    Sezaki H; Arase Y; Tsubota A; Suzuki Y; Kobayashi M; Saitoh S; Suzuki F; Akuta N; Someya T; Ikeda K; Kumada H
    J Gastroenterol; 2003; 38(5):493-500. PubMed ID: 12768394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune hepatitis in the HIV-infected patient: a therapeutic dilemma.
    Wan DW; Marks K; Yantiss RK; Talal AH
    AIDS Patient Care STDS; 2009 Jun; 23(6):407-13. PubMed ID: 19405870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
    Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune hepatitis in a HIV-HCV co-infected patient: diagnostic ant therapeutic difficulties].
    Cazanave C; Rakotondravelo S; Morlat P; Blanco P; Bonnet F; Beylot J
    Rev Med Interne; 2006 May; 27(5):414-9. PubMed ID: 16545501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient.
    Coriat R; Podevin P
    Int J STD AIDS; 2008 Mar; 19(3):208-10. PubMed ID: 18397566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation.
    Salcedo M; Rodríguez-Mahou M; Rodríguez-Sainz C; Rincón D; Alvarez E; Vicario JL; Catalina MV; Matilla A; Ripoll C; Clemente G; Bañares R
    Liver Transpl; 2009 May; 15(5):530-9. PubMed ID: 19399747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection.
    Matsumoto K; Kikuchi K; Kajiyama Y; Takano Y; Mabuchi M; Doi S; Sato K; Miyakawa H; Yasuda I
    Intern Med; 2018 Sep; 57(18):2669-2673. PubMed ID: 29709942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis.
    Efe C; Ozaslan E; Heurgué-Berlot A; Kav T; Masi C; Purnak T; Torgutalp M; Muratori L; Bresson-Hadni S; Thiéfin G; Schiano TD; Muratori P; Wahlin S
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):532-7. PubMed ID: 24614697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.
    Montano-Loza AJ; Vargas-Vorackova F; Ma M; Bain VG; Burak K; Kumar T; Mason AL
    Liver Int; 2012 Oct; 32(9):1426-33. PubMed ID: 22712495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy.
    D'Ambrosio R; Aghemo A; Rumi MG; Primignani M; Dell'Era A; Lampertico P; Donato MF; De Nicola S; Prati GM; de Franchis R; Colombo M
    Antivir Ther; 2011; 16(5):677-84. PubMed ID: 21817189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.